Ken Griffin Sana Biotechnology, Inc. Put Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$3.76 - $6.86 $432,776 - $789,586	-115,100 Reduced 90.35%	12,300 $51,000
Q2 2024 Aug 14, 2024	BUY	$5.23 - $10.44 $504,695 - $1.01 Million	96,500 Added 312.3%	127,400 $695,000
Q1 2024 May 15, 2024	BUY	$4.2 - $11.27 $126,000 - $338,100	30,000 Added 3333.33%	30,900 $309,000
Q4 2023 Feb 14, 2024	SELL	$2.8 - $4.55 $20,160 - $32,760	-7,200 Reduced 88.89%	900 $3,000
Q3 2023 Nov 14, 2023	BUY	$3.77 - $6.23 $26,013 - $42,987	6,900 Added 575.0%	8,100 $31,000
Q2 2023 Aug 14, 2023	SELL	$3.22 - $7.53 $27,692 - $64,758	-8,600 Reduced 87.76%	1,200 $7,000
Q1 2023 May 15, 2023	BUY	$3.11 - $4.92 $12,440 - $19,680	4,000 Added 68.97%	9,800 $32,000
Q4 2022 Feb 14, 2023	SELL	$3.19 - $6.46 $13,398 - $27,132	-4,200 Reduced 42.0%	5,800 $22,000
Q3 2022 Nov 14, 2022	BUY	$5.58 - $9.04 $55,800 - $90,399	10,000 New	10,000 $60,000

174

121M

1.87M

1.48M

Ticker SANA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 190,232,000
Market Cap $306M
Description
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.